Generics 7

Originals

Biosimilars

Medical devices

Nutraceuticals 1

Filters

Dextrose anhydride manufacturers

7 products found

Filters

7 products found

dextrose anhydride

Solution for injection/infusion 3.33 g / mL

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bolivia
GMP approvals
WHO
Manufacturer #17273
The company was formed more than 80 years ago. They develop and market health, beauty, and wellness products. They are committed to excellence in service and quality, and responsibility to society. They have Divided pharmaceuticals into five sections: large volume solutions (serums), small volume solutions (injectables), powders, liquids, and solids.

Manufacturer usually replies in 3 days

dextrose anhydride

Bags for injection/infusion 5 %, 10 %, 20 %, 30 %, 50 % - 50 ml, 100 ml, 150 ml, 250 ml, 500 ml, 1000 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #2272
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.

Manufacturer usually replies in 7 days

dextrose anhydride

Ampoules, injection 30% w/v, 50% w/v

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
Manufacturer #1447
The company was established in the early 1990s. It is one of the largest integrated pharmaceutical groups with a firm focus on protecting the nation via providing accessible and affordable healthcare solutions, with operations in Malaysia and Indonesia. It is involved in various segments of the pharmaceutical value chain, including research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales and marketing, as well as a community pharmacy.

Manufacturer usually replies in 6 days

dextrose anhydride

Injection 25 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19051

Manufacturer usually replies in 14 days

dextrose anhydride + sodium chloride

Bags for injection/infusion 3.33 % + 0.3 %, 3.75 % + 0.225 %, 5 % + 0.2 %, 5 % + 0.45 %, 5 % + 0.9 % - 100 ml, 150 ml, 250 ml, 500 ml, 1000 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #2272
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.

Manufacturer usually replies in 7 days

bupivacaine + dextrose anhydride

Injection 5 mg, 80 mg/ml - 4 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20982

Manufacturer usually replies in 8 days

theophylline + dextrose anhydride

Bags for injection/infusion 0.2 g + 4.5 g / 100 ml, 0.4 g + 22.5g / 500 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #17874
To contribute to the protection of human health, the elimination of health problems, and the improvement of quality of life through their products, which the company develops in light of scientific developments using pioneering and innovative approaches while taking into account the requirements of safety, the environment, and Good Manufacturing Practices (GMP); and to create value for the local market.

Manufacturer usually replies in 13 days

Dextrose Anhydride manufacturers

Dextrose is used to treat hypoglycemia (low blood sugar), which is most commonly seen in patients with diabetes. Insulin shock is treated with dextrose, which is administered as an injection. This medication works by rapidly raising the amount of glucose in your bloodstream. It can also be used to help people who are unable to eat due to illness, accident, or another medical condition. It is sometimes administered to those who have been sick as a result of consuming too much alcohol.

How does Dextrose Anhydride work?

Glucose generates the energy molecules ATP and NADH during a sequence of metabolism events known as glycolysis, which provides the majority of the energy to all tissues. Glycolysis is separated into two steps, with the preliminary phase beginning with the phosphorylation of sugar by a hexokinase to produce glucose 6-phosphate. The rate-limiting step is the insertion of the high-energy phosphate group, which activates glucose for further breakdown in later phases of glycolysis. Following reactions use the products as substrates to transform the C6 molecule into two C3 simple sugars. These products reach the energy-releasing phase, when each glucose molecule generates 4 ATP and 2 NADH molecules. An IV is used to deliver dextrose into a vein. This drug should not be injected into a muscle or under the skin. Only intravenous (IV) injections should be provided, and they should be given gently. When Dextrose is injected, tell your caretakers if you have any burning, pain, or swelling around the IV needle.

Pricing of Dextrose Anhydride

It is sold at different prices by a number of producers and distributors. Depending on the pharmacy you visit, Dextrose intravenous solution 25 percent costs roughly $90 for a supply of 100 millilitres.. Pharmaceutical corporations generally support patient assistance programmes (PAPs), which provide free or subsidised drugs to low-income, unemployed, or under-insured people who meet certain criteria.

Supplying Dextrose Anhydride Manufacturers and Suppliers

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Dextrose Anhydride offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Dextrose Anhydride. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Dextrose Anhydride is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over this medicine offer with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Dextrose Anhydride manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.